effect O O
of O O
rasapravicharana B-Dg O
cikitsa E-Dg O
in O O
kapha O O
dominance O O
of O O
tamaka O O
swasa O O
a O O
case O O
series O O
rasapravicharana B-Dg O
cikitsa E-Dg O
is O O
the O O
administration O O
of O O
drugs O O
in O O
accordance O O
with O O
the O O
rasam O O
after O O
assessing O O
the O O
doshic O O
imbalance O O
in O O
diseases O O
the O O
basic O O
approach O O
of O O
ayurveda O O
is O O
to O O
normalize O O
the O O
doshas O O
in O O
aggravated O O
or O O
depleted O O
conditions O O
occurred O O
in O O
the O O
manifestation O O
of O O
disease O O
the O O
objective O O
of O O
the O O
study O O
was O O
to O O
assess O O
the O O
effect O O
of O O
rasapravicharana B-Dg O
cikitsa E-Dg O
in O O
aggravated B-Ds O
kapha I-Ds O
dosha E-Ds O
of O O
kapha O O
dominant O O
tamaka O O
swasa O O
the O O
study O O
was O O
conducted O O
on O O
patients O O
between O O
the O O
age O O
group O O
to O O
yrs O O
of O O
both O O
the O O
sexes O O
the O O
patients O O
were O O
administered O O
with O O
katu B-Dg O
rasa I-Dg O
drug I-Dg O
powder E-Dg O
of O O
the O O
dried O O
fruit O O
of O O
maricham O O
piper O O
nigrum O O
linn O O
at O O
the O O
dose O O
of O O
tikta B-Dg O
bitter I-Dg O
rasa I-Dg O
drug E-Dg O
dried B-Dg O
vasa I-Dg O
leaf I-Dg O
powder E-Dg O
adhatoda B-Dg O
vasica I-Dg O
nees E-Dg O
at O O
the O O
dose O O
of O O
and O O
kashaya B-Dg O
astringent I-Dg O
rasa I-Dg O
drug I-Dg O
powder E-Dg O
of O O
the O O
dried O O
fruit O O
pericarp O O
of O O
haritaki O O
terminalia O O
chebula O O
gaertn O O
retz O O
at O O
the O O
dose O O
of O O
am O O
and O O
after O O
food O O
daily O O
in O O
luke O O
warm O O
water O O
respectively O O
for O O
a O O
period O O
of O O
two O O
weeks O O
each O O
the O O
katu B-Dg O
rasa I-Dg O
drug E-Dg O
administered O O
for O O
days O O
produced O O
highly O O
significant O O
reduction O O
in O O
dyspnoea S-Ds O
cough B-Ds O
bout E-Ds O
frequency O O
wheeze B-Ds O
expectoration O O
of O O
sputum S-Ds O
and O O
quantity O O
of O O
sputum S-Ds O
and O O
significant O O
improvement O O
in O O
pefrate O O
but O O
no O O
significant O O
improvement O O
was O O
observed O O
in O O
pef O O
the O O
administration O O
of O O
tikta B-Dg O
rasa I-Dg O
drug E-Dg O
in O O
the O O
next O O
days O O
resulted O O
in O O
highly O O
significant O O
reduction O O
in O O
cough B-Ds O
bout E-Ds O
frequency O O
and O O
expectoration O O
of O O
sputum S-Ds O
and O O
significant O O
reduction O O
in O O
dyspnoea S-Ds O
the O O
reduction O O
was O O
maintained O O
in O O
other O O
signs O O
and O O
symptoms O O
the O O
kashaya B-Dg O
rasa I-Dg O
drug E-Dg O
used O O
in O O
the O O
last O O
days O O
significantly O O
improved O O
pefrate O O
reduction O O
in O O
other O O
signs O O
and O O
symptoms O O
was O O
maintained O O
the O O
management O O
according O O
to O O
rasapravicharana B-Dg O
cikitsa E-Dg O
has O O
a O O
significant O O
role O O
in O O
the O O
pacification O O
of O O
doshas O O
involved O O
in O O
the O O
manifestation O O
of O O
diseases O O

clinical O O
study O O
to O O
evaluate O O
the O O
efficacy O O
of O O
punarnava B-Dg O
churna E-Dg O
on O O
vyana B-Ds O
bala I-Ds O
vaishamya E-Ds O
in O O
essential O O
hypertension S-Ds O
mainly O O
vata B-Ds O
prakopa I-Ds O
occurs O O
particularly O O
vyana O O
vata O O
as O O
it O O
is O O
responsible O O
for O O
rakta O O
samvahana O O
by O O
virtue O O
of O O
its O O
ruksha O O
sheeta O O
and O O
khara O O
guna O O
vahini O O
dhamanis O O
are O O
constricted O O
also O O
its O O
ruksha O O
guna O O
dries O O
the O O
malarupa O O
kapha O O
at O O
the O O
inner O O
side O O
of O O
the O O
vessels O O
making O O
them O O
more O O
rigid O O
vascular O O
lumen O O
may O O
be O O
reduced O O
further O O
leading O O
to O O
obstruction O O
in O O
it O O
so O O
for O O
normal O O
circulatory O O
function O O
increased O O
force O O
of O O
vyana O O
vayu O O
is O O
required O O
resulting O O
into O O
vyana B-Dg O
bala I-Dg O
vaishamya E-Dg O
and O O
hence O O
leading O O
to O O
the O O
development O O
of O O
hypertension S-Dg O
the O O
who O O
rates O O
hypertension S-Dg O
as O O
one O O
of O O
the O O
most O O
important O O
causes O O
of O O
premature O O
death O O
worldwide O O
worldwide O O
approximately O O
billion O O
people O O
have O O
hypertension S-Dg O
contributing O O
to O O
more O O
than O O
million O O
deaths O O
per O O
year O O
the O O
number O O
of O O
adults O O
with O O
hypertension S-Dg O
in O O
is O O
predicted O O
to O O
increase O O
by O O
about O O
to O O
a O O
total O O
of O O
around O O
billion O O
in O O
india O O
cardiovascular O O
diseases O O
caused O O
million O O
deaths O O
in O O
the O O
year O O
this O O
is O O
projected O O
to O O
double O O
by O O
the O O
year O O
numbers O O
of O O
drugs O O
are O O
available O O
in O O
modern O O
medicine O O
to O O
treat O O
the O O
disease O O
in O O
its O O
symptomatically O O
active O O
state O O
but O O
still O O
are O O
unable O O
to O O
cure O O
the O O
hypertension S-Dg O
hyper O O
function O O
of O O
vyana O O
is O O
considered O O
under O O
vyana B-Dg O
bala I-Dg O
vaishamya E-Dg O
which O O
produces O O
increased O O
force O O
in O O
the O O
wall O O
of O O
the O O
channels O O
blood O O
vessels O O
to O O
produce O O
the O O
disease O O
hypertension S-Dg O
in O O
the O O
present O O
clinical O O
trial O O
punarnava B-Dg O
churna E-Dg O
is O O
orally O O
administered O O
for O O
month O O
twice O O
a O O
day O O
after O O
food O O
clinically O O
diagnosed O O
patients O O
of O O
hypertension S-Dg O
were O O
randomly O O
selected O O
and O O
divided O O
into O O
two O O
groups O O
cbc O O
rbs O O
ecg O O
blood O O
urea O O
serum O O
creatinine O O
and O O
lipid O O
profile O O
were O O
done O O
before O O
and O O
after O O
the O O
clinical O O
trial O O
after O O
completion O O
of O O
study O O
signs O O
and O O
symptoms O O
were O O
controlled O O
significantly O O
and O O
also O O
there O O
were O O
significant O O
changes O O
in O O
laboratory O O
findings O O

mode O O
of O O
action O O
of O O
amritadya B-Dg O
guggulu E-Dg O
in O O
the O O
management O O
of O O
to O O
obesity B-Ds O
sthoulya E-Ds O
is O O
the O O
major O O
and O O
basic O O
cause O O
of O O
lifestyle O O
disorders O O
like O O
diabetes S-Ds O
mellitus S-Ds O
coronary B-Ds O
heart I-Ds O
disease E-Ds O
hypertension S-Ds O
obesity S-Ds O
is O O
increasing O O
at O O
an O O
alarming O O
rate O O
in O O
developed O O
industrialized O O
countries O O
which O O
are O O
undergoing O O
rapid O O
nutrition O O
and O O
lifestyle O O
transition O O
obesity S-Ds O
is O O
one O O
of O O
the O O
most O O
effective O O
diseases O O
which O O
affect O O
someone O O
s O O
social O O
physical O O
and O O
mental O O
status O O
in O O
ayurveda O O
sthoulya B-Ds O
obesity E-Ds O
is O O
regarded O O
as O O
medoroga S-Ds O
a O O
disorder B-Ds O
of I-Ds O
meda I-Ds O
dhatu E-Ds O
which O O
includes O O
fat O O
tissue O O
and O O
fat O O
metabolism O O
according O O
to O O
ayurveda O O
sthoulya S-Ds O
begins O O
with O O
an O O
imbalance O O
of O O
doshas O O
vata O O
pitta O O
and O O
kapha O O
agni O O
digestive O O
fire O O
malas O O
waste O O
products O O
or O O
an O O
imbalance O O
of O O
srotas O O
microcirculatory O O
channels O O
this O O
collection O O
of O O
imbalances O O
then O O
interferes O O
with O O
the O O
formation O O
of O O
tissues O O
or O O
dhatus O O
and O O
leads O O
to O O
a O O
tissue O O
imbalance O O
that O O
we O O
experience O O
as O O
excess B-Ds O
weight E-Ds O
overweight S-Ds O
and O O
obesity S-Ds O
are O O
linked O O
to O O
more O O
deaths O O
worldwide O O
than O O
underweight S-Ds O
overall O O
about O O
of O O
the O O
world O O
adult O O
population O O
of O O
men O O
and O O
of O O
women O O
was O O
obese O O
in O O
the O O
worldwide O O
prevalence O O
of O O
obesity S-Ds O
nearly O O
tripled O O
between O O
and O O
amritadya B-Dg O
guggulu E-Dg O
possesses O O
katu B-Dg O
tikta I-Dg O
kashaya I-Dg O
laghu I-Dg O
ruksha E-Dg O
and O O
ushna B-Dg O
katu I-Dg O
dosha I-Dg O
kapha I-Dg O
vatashamaka E-Dg O
is O O
effective O O
in O O
the O O
management O O
of O O
sthoulya S-Ds O
by O O
virtue O O
of O O
its O O
rasapanchaka O O
contents O O
of O O
drug O O
are O O
very O O
well O O
indicated O O
in O O
kapha O O
predominant O O
pathologies O O
due O O
to O O
this O O
property O O
it O O
breaks O O
the O O
samprapti O O
of O O
sthoulya S-Ds O
hence O O
the O O
present O O
attempt O O
is O O
done O O
to O O
encompass O O
the O O
up O O
to O O
date O O
comprehensive O O
literature O O
to O O
study O O
the O O
mode O O
of O O
action O O
of O O
amritadya B-Dg O
guggulu E-Dg O
in O O
the O O
management O O
of O O
sthoulya S-Ds O
to O O
ayurvedic O O
properties O O
and O O
modern O O
pharmacology O O

importance O O
of O O
raktamokshana S-Dg O
in O O
the O O
management O O
of O O
tvachavikar S-Ds O
nowadays O O
tvachavikar S-Ds O
is O O
most O O
common O O
skin B-Ds O
disease E-Ds O
and O O
it O O
has O O
social O O
impact O O
it O O
is O O
a O O
skin O O
problem O O
mentioned O O
in O O
ayurvedic O O
literature O O
with O O
kapha O O
and O O
pitta O O
morbidly O O
or O O
pathology O O
in O O
classical O O
different O O
text O O
of O O
ayurveda O O
and O O
acharyas O O
emphasize O O
the O O
shodhana O O
as O O
the O O
line O O
of O O
treatment O O
at O O
various O O
places O O
in O O
shodhana O O
treatment O O
raktamokshan S-Dg O
is O O
highlight O O
specially O O
because O O
in O O
samprapti O O
ghataka O O
rakta O O
is O O
mainly O O
involved O O
as O O
dushya O O
in O O
the O O
present O O
topic O O
raktamokshana S-Dg O
acharya O O
sushruta O O
propounds O O
practical O O
guidelines O O
for O O
bloodletting O O
and O O
claims O O
it O O
as O O
most O O
effective O O
therapy O O
in O O
half O O
of O O
the O O
body O O
ailments O O
in O O
all O O
different O O
methods O O
for O O
bloodletting O O
such O O
as O O
jalaukavacharana B-Dg O
karma E-Dg O
prachhanna B-Dg O
karma E-Dg O
and O O
siravedhana B-Dg O
karma E-Dg O
jalaukaavacharna B-Dg O
karma I-Dg O
therapy E-Dg O
is O O
considered O O
as O O
the O O
ideal O O
method O O
to O O
expel O O
out O O
the O O
vitiated O O
blood O O
safely O O
quickly O O
and O O
effectively O O
the O O
vitiated O O
external O O
environment O O
undoubtedly O O
affects O O
the O O
body O O
s O O
internal O O
ailments O O
large O O
community O O
prevalence O O
studies O O
have O O
demonstrated O O
that O O
about O O
of O O
the O O
world O O
population O O
have O O
various O O
skin B-Dg O
problems E-Dg O
requiring O O
attention O O
so O O
raktamokshan S-Dg O
is O O
one O O
of O O
the O O
important O O
panckarma B-Fn O
treatments E-Fn O
to O O
cure O O
various O O
type O O
of O O
tvacha O O
vikar O O
highlighting O O
in O O
this O O
topic O O

in O O
vivo O O
study O O
of O O
efficacy O O
of O O
trailokyasundar B-Dg O
rasa E-Dg O
in O O
chronic B-Ds O
myeloid I-Ds O
leukemia E-Ds O
trailokyasundar B-Dg O
rasa E-Dg O
is O O
one O O
of O O
the O O
rasakalpa O O
which O O
is O O
explained O O
in O O
rasaratnasamucchaya O O
and O O
is O O
suggestive O O
of O O
its O O
efficacy O O
in O O
pandu O O
roga O O
pandu O O
roga O O
is O O
a O O
pitta O O
pradhanavyadhi O O
in O O
which O O
rasadhatu O O
and O O
raktadhatu O O
are O O
mainly O O
affected O O
according O O
to O O
modern O O
texts O O
all O O
disorders O O
of O O
vitiated O O
digestion O O
absorption O O
and O O
assimilation O O
can O O
be O O
considered O O
under O O
pandu O O
according O O
to O O
modern O O
texts O O
all O O
disorders O O
of O O
vitiated O O
digestion O O
absorption O O
and O O
assimilation O O
can O O
be O O
considered O O
under O O
pandu O O
therefore O O
it O O
can O O
be O O
said O O
that O O
pandu O O
is O O
a O O
very O O
broad O O
term O O
comprising O O
various O O
rasa O O
and O O
raktpradoshajvikara O O
such O O
as O O
anaemia S-Ds O
megaloblastic S-Ds O
anaemia S-Ds O
blood S-Ds O
disorders S-Ds O
leukemia S-Ds O
s O O
etc O O
the O O
activity O O
of O O
trailokyasundar O O
rasa O O
is O O
highly O O
significant O O
by O O
reducing O O
tumour O O
volume O O
and O O
growth O O
inhibition O O
in O O
animal O O
models O O
of O O
chronic B-Ds O
myeloid I-Ds O
leukemia E-Ds O
on O O
the O O
of O O
the O O
experiment O O
tumour O O
size O O
of O O
the O O
control O O
group O O
was O O
comparatively O O
in O O
the O O
study O O
group O O
mean O O
tumour O O
size O O
was O O
of O O
also O O
it O O
prevented O O
decrease O O
in O O
the O O
platelet O O
count O O
and O O
as O O
compared O O
to O O
untreated O O
mice O O
of O O
cml O O
rate O O
of O O
increment O O
of O O
wbc O O
s O O
was O O
also O O
comparatively O O
reduced O O
in O O
trailokyasundar B-Dg O
rasa E-Dg O
treated O O
mice O O

role O O
of O O
and O O
yogic B-Dg O
procedures E-Dg O
in O O
the O O
management O O
of O O
chronic B-Ds O
obstructive I-Ds O
pulmonary I-Ds O
disease E-Ds O
copd S-Ds O
is O O
a O O
chronic B-Ds O
lung I-Ds O
disease E-Ds O
that O O
is O O
often O O
preventable O O
and O O
treatable O O
in O O
ayurvedic O O
texts O O
shwasa B-Ds O
roga E-Ds O
has O O
been O O
described O O
having O O
symptomatology O O
close O O
to O O
copd S-Ds O
copd S-Ds O
damages B-Fn O
the I-Fn O
airways I-Fn O
in I-Fn O
lungs E-Fn O
and O O
leads B-Fn O
to I-Fn O
shortness I-Fn O
of I-Fn O
breath E-Fn O
impacting O O
work O O
exercise O O
sleep O O
and O O
other O O
everyday O O
activities O O
more O O
than O O
million O O
people O O
in O O
the O O
suffer O O
from O O
copd S-Ds O
and O O
its O O
prevalence O O
has O O
been O O
increasing O O
steadily O O
over O O
the O O
past O O
years O O
it O O
causes O O
serious O O
disability O O
and O O
early O O
death O O
copd S-Ds O
includes O O
both O O
chronic B-Ds O
bronchitis E-Ds O
and O O
emphysema S-Ds O
risk O O
factor O O
includes O O
exposure O O
to O O
air O O
pollution O O
smoke O O
and O O
occupational O O
dusts O O
and O O
chemicals O O
smoking O O
cold O O
weather O O
etc O O
which O O
are O O
also O O
mentioned O O
in O O
ayurvedic O O
classics O O
identification O O
reduction O O
and O O
control O O
of O O
risk O O
factors O O
to O O
prevent O O
the O O
onset O O
of O O
copd S-Ds O
are O O
important O O
steps O O
towards O O
developing O O
strategies O O
for O O
prevention O O
of O O
copd S-Ds O
the O O
aims O O
and O O
objectives O O
of O O
ayurveda O O
are O O
to O O
maintain O O
the O O
health O O
of O O
a O O
healthy O O
person O O
and O O
to O O
cure O O
the O O
diseases O O
of O O
the O O
patients O O
it O O
is O O
signifies O O
that O O
prevention O O
is O O
better O O
than O O
to O O
maintain O O
the O O
health O O
ayurveda O O
laid O O
many O O
basic O O
principles O O
like O O
ritucharya O O
dincharya O O
etc O O
the O O
yogic B-Dg O
procedures E-Dg O
and O O
the O O
concept O O
of O O
pathya O O
and O O
apathya O O
unwholesome O O
is O O
the O O
peculiarity O O
of O O
ayurveda O O
for O O
the O O
management O O
of O O
copd S-Ds O
and O O
the O O
treatment O O
module O O
panchakarma B-Dg O
vamana I-Dg O
virechana I-Dg O
dhumapana E-Dg O
and O O
nasya B-Dg O
external O O
therapies O O
lepas B-Dg O
dhara I-Dg O
sthanika I-Dg O
abhayanga E-Dg O
and O O
swedana S-Dg O
and O O
internal O O
medications O O
are O O
very O O
effective O O
in O O
copd S-Ds O

study O O
the O O
efficacy O O
of O O
khadiradi B-Dg O
kwath E-Dg O
in O O
the O O
management O O
of O O
bhagandara S-Ds O
to O O
fistula O O
in O O
ano O O
from O O
the O O
origin O O
of O O
civilization O O
the O O
people O O
suffered O O
from O O
various O O
diseases O O
and O O
among O O
the O O
many O O
uncomfortable O O
conditions O O
guda B-Ds O
roga E-Ds O
is O O
one O O
of O O
the O O
most O O
important O O
one O O
the O O
disease O O
is O O
widely O O
prevalent O O
and O O
numerous O O
options O O
are O O
being O O
practiced O O
for O O
its O O
management O O
is O O
one O O
condition O O
for O O
which O O
the O O
maximum O O
types O O
of O O
surgical O O
parasurgical O O
and O O
medical O O
applications O O
have O O
been O O
described O O
this O O
divergent O O
approach O O
to O O
the O O
treatment O O
for O O
a O O
single O O
disease O O
is O O
only O O
suggestive O O
of O O
the O O
fact O O
that O O
none O O
of O O
these O O
methods O O
is O O
complete O O
or O O
satisfactory O O
sushruta O O
described O O
a O O
detailed O O
surgical O O
approach O O
involving O O
excision O O
of O O
the O O
fistulous O O
tract O O
but O O
also O O
felt O O
the O O
necessity O O
of O O
a O O
parasurgical O O
approach O O
since O O
he O O
was O O
not O O
quite O O
satisfied O O
with O O
the O O
surgical O O
excision O O
which O O
often O O
resulted O O
into O O
recurrence O O
however O O
they O O
limited O O
this O O
alternative O O
method O O
called O O
ksharasutra S-Dg O
in O O
selected O O
cases O O
only O O
in O O
which O O
found O O
unfit O O
for O O
surgery O O
due O O
to O O
ksharsutra B-Dg O
procedure E-Dg O
recurrence O O
rate O O
is O O
almost O O
nil O O
but O O
it O O
takes O O
very O O
long O O
duration O O
to O O
cut O O
and O O
heal O O
the O O
track O O
khadiradi B-Dg O
kwaths E-Dg O
helps O O
to O O
inhibit O O
to O O
break O O
pathogenesis O O
of O O
bhagandara O O
in O O
short O O
time O O
and O O
also O O
prevent O O
the O O
recurrence O O
rate O O
of O O
bhagandara S-Ds O
and O O
hence O O
recurrence O O
rate O O
is O O
nearly O O
nil O O
and O O
it O O
does O O
not O O
take O O
very O O
long O O
duration O O
to O O
cut O O
and O O
heal O O
the O O
track O O
of O O
bhagandara O O
with O O
minimum O O
expenditure O O
in O O
our O O
present O O
study O O
we O O
have O O
taken O O
patients O O
in O O
two O O
groups O O
patients O O
in O O
each O O
group O O
the O O
first O O
group O O
is O O
experimental O O
group O O
khadiradi B-Dg O
kwath E-Dg O
along O O
with O O
standard O O
ksharsutra S-Dg O
and O O
second O O
is O O
control O O
group O O
only O O
ksharsutra S-Dg O
we O O
have O O
taken O O
observations O O
viz O O
age O O
sex O O
occupation O O
agni O O
koshtha O O
etc O O
by O O
which O O
we O O
can O O
observe O O
the O O
characteristics O O
of O O
disease O O
in O O
these O O
conditions O O
to O O
assess O O
the O O
nature O O
of O O
disease O O
we O O
have O O
taken O O
assessment O O
criteria O O
like O O
pain O O
discharge O O
in O O
duration O O
foul O O
smell O O
burning O O
sensation O O
itching O O
from O O
above O O
criteria O O
we O O
made O O
the O O
result O O
of O O
effectiveness O O
of O O
treatment O O
by O O
using O O
t O O
test O O
on O O
level O O
of O O
significance O O

efficacy O O
of O O
dhanyamla B-Dg O
sarvanga I-Dg O
dhara E-Dg O
in O O
the O O
management O O
of O O
obesity S-Ds O
an O O
analytical O O
review O O
obesity S-Ds O
consist O O
a O O
major O O
nutritional O O
health O O
problem O O
in O O
developed O O
and O O
developing O O
countries O O
which O O
has O O
reached O O
epidemic O O
proportions O O
it O O
is O O
a O O
medical O O
condition O O
of O O
excessive O O
fat O O
accumulation O O
to O O
the O O
extent O O
that O O
it O O
may O O
have O O
negative O O
effect O O
on O O
health O O
obesity O O
are O O
major O O
causes O O
of O O
including O O
type O O
diabetes S-Ds O
cardiovascular B-Ds O
disease E-Ds O
various O O
cancer S-Ds O
and O O
other O O
health O O
problem O O
like O O
obstructive B-Ds O
sleep E-Ds O
apnea S-Ds O
osteoarthritis S-Ds O
and O O
depression S-Ds O
obesity S-Ds O
is O O
most O O
commonly O O
caused O O
by O O
a O O
combination O O
of O O
excessive O O
food O O
intake O O
lack O O
of O O
physical O O
activity O O
leptin O O
enzyme O O
is O O
responsible O O
for O O
controlling O O
appetite O O
through O O
its O O
action O O
on O O
cns O O
tnf O O
alpha O O
is O O
also O O
link O O
factor O O
between O O
fat O O
accumulation O O
and O O
metabolic O O
disorders O O
the O O
body O O
mass O O
index O O
is O O
an O O
internationally O O
accepted O O
index O O
to O O
estimate O O
body O O
weight O O
taking O O
medication O O
like O O
sibutramine O O
orlistat O O
as O O
an O O
option O O
for O O
treatment O O
of O O
obesity S-Ds O
can O O
be O O
given O O
because O O
it O O
is O O
associated O O
with O O
many O O
side O O
effects O O
bariatric O O
surgery O O
may O O
be O O
performed O O
to O O
reduce O O
weight O O
but O O
it O O
is O O
not O O
very O O
useful O O
treatment O O
diet O O
life O O
style O O
modification O O
physical O O
activity O O
can O O
achieve O O
the O O
desired O O
loss O O
of O O
body O O
fat O O
in O O
ayurveda O O
best O O
treatment O O
for O O
sthaulya S-Ds O
defined O O
by O O
acharyacharak O O
and O O
sushruta O O
and O O
vagbhatt O O
dhanyamala O O
sarvanga O O
dhara O O
is O O
highly O O
effective O O
in O O
vata O O
associated O O
with O O
ama O O
and O O
kapha O O
dhanyamla O O
sarvanga O O
dhara O O
eliminates O O
the O O
body O O
toxins O O
establishes O O
health O O
and O O
tones O O
up O O
the O O
joints O O
and O O
soft O O
tissues O O
the O O
drug O O
will O O
act O O
soon O O
as O O
the O O
medicine O O
touches O O
the O O
skin O O
surface O O
due O O
to O O
vasodilation B-Fn O
property E-Fn O
blood O O
flow O O
will O O
increase O O
through O O
the O O
area O O
increasing B-Fn O
metabolism E-Fn O
further O O
eliminating O O
the O O
toxins O O
which O O
will O O
help O O
in O O
reducing O O
the O O
obesity S-Ds O
dhanyamala O O
sarvanga O O
dhara O O
controls O O
the O O
disease O O
process O O
and O O
may O O
cause O O
long O O
lasting O O
relief O O

comparative O O
study O O
on O O
efficacy O O
of O O
eranda B-Dg O
haritaki E-Dg O
and O O
eranda B-Dg O
shunti E-Dg O
the O O
management O O
of O O
amavata S-Ds O
amavata S-Ds O
is O O
a O O
disease O O
described O O
in O O
detail O O
by O O
madhavakara O O
in O O
madava O O
nidana O O
the O O
word O O
amavata S-Ds O
is O O
made O O
up O O
of O O
ama O O
and O O
vata O O
aam O O
is O O
produced O O
due O O
to O O
derangement O O
of O O
jatharagni O O
this O O
aam O O
then O O
gets O O
accumulated O O
in O O
kostha O O
sandhi O O
and O O
trika O O
with O O
vitiated O O
vata O O
and O O
produce O O
stabdhata O O
in O O
body O O
swelling O O
over O O
joints O O
and O O
severe O O
pain O O
in O O
multiple O O
joints O O
this O O
condition O O
is O O
called O O
aamvata S-Ds O
this O O
clinical O O
feature O O
of O O
aamvata S-Ds O
is O O
markedly O O
similar O O
to O O
rheumatoid B-Ds O
arthritis E-Ds O
which O O
is O O
a O O
chronic O O
autoimmune O O
disease O O
aim O O
to O O
compare O O
the O O
efficacy O O
of O O
erandaharitaki S-Dg O
erandashunti S-Dg O
as O O
abhyantarpana O O
and O O
matrabasti O O
in O O
aamvata O O
materials O O
methods O O
in O O
the O O
present O O
study O O
patients O O
in O O
of O O
aamvata S-Ds O
having O O
aged O O
between O O
to O O
years O O
fulfilling O O
the O O
inclusion O O
criteria O O
were O O
selected O O
from O O
the O O
opd O O
and O O
ipd O O
of O O
kayachikitsa O O
department O O
of O O
mgach O O
salod O O
wardha O O
maharashtra O O
all O O
patients O O
were O O
investigated O O
for O O
esr O O
and O O
titre O O
and O O
were O O
treated O O
in O O
two O O
different O O
groups O O
with O O
administration O O
of O O
erandaharitaki S-Dg O
in O O
group O O
a O O
and O O
eranda B-Dg O
sunthi E-Dg O
in O O
group O O
was O O
given O O
for O O
abhyantar B-Dg O
pana E-Dg O
and O O
matrabasti S-Dg O
results O O
after O O
the O O
treatment O O
of O O
days O O
the O O
improvement O O
was O O
observed O O
in O O
the O O
symptoms O O
of O O
both O O
the O O
groups O O
the O O
result O O
of O O
this O O
treatment O O
showed O O
the O O
improvement O O
was O O
better O O
in O O
group O O
a O O
abhyantarpana B-Dg O
matrabasti I-Dg O
with I-Dg O
erandaharitaki I-Dg O
tailam E-Dg O
in O O
comparison O O
to O O
group O O
abhyantarpana B-Dg O
matrabasti I-Dg O
with I-Dg O
erandashunti I-Dg O
tailam E-Dg O
conclusion O O
the O O
present O O
study O O
revealed O O
the O O
efficacy O O
of O O
ayurveda O O
therapy O O
including O O
both O O
abhyantarpana S-Dg O
and O O
matrabasti S-Dg O
for O O
duration O O
of O O
days O O
in O O
the O O
management O O
of O O
aamvata S-Ds O

efficacy O O
of O O
matrabasti S-Dg O
on O O
kashtartava S-Ds O
in O O
today O O
s O O
lifestyle O O
woman O O
s O O
status O O
is O O
expected O O
to O O
reach O O
new O O
horizons O O
both O O
socially O O
and O O
physically O O
but O O
some O O
of O O
the O O
physiological O O
things O O
trouble O O
the O O
lady O O
to O O
make O O
her O O
slow O O
down O O
the O O
race O O
by O O
disturbing O O
the O O
normal O O
menstruation O O
which O O
is O O
the O O
function O O
of O O
apana B-Ds O
vayu E-Ds O
one O O
of O O
such O O
problem O O
is O O
kashtartava B-Ds O
painful I-Ds O
menstruation E-Ds O
in O O
ayurvedic O O
texts O O
though O O
various O O
conditions O O
are O O
described O O
in O O
which O O
menstruation O O
occurs O O
with O O
pain O O
but O O
kashtartava S-Ds O
is O O
not O O
mentioned O O
specifically O O
it O O
is O O
a O O
symptom O O
of O O
various O O
yonivyapadas O O
specially O O
udavarta O O
vatala O O
sannipatika O O
etc O O
the O O
genital O O
tract O O
of O O
women O O
does O O
not O O
get O O
affected O O
without O O
vata O O
hence O O
one O O
should O O
pacify O O
it O O
first O O
and O O
then O O
treat O O
the O O
other O O
doshas O O
for O O
vata O O
dosha O O
basti O O
chikitsa O O
is O O
very O O
important O O
matrabasti S-Dg O
is O O
used O O
by O O
someone O O
who O O
emaciated O O
by O O
overwork O O
or O O
too O O
much O O
exercise O O
too O O
much O O
heavy O O
lifting O O
walking O O
too O O
long O O
of O O
a O O
distance O O
too O O
much O O
sexual O O
activity O O
or O O
someone O O
with O O
vata O O
disorders O O
one O O
of O O
the O O
effects O O
of O O
matrabasti S-Dg O
is O O
vatarognut O O
hence O O
matrabasti O O
may O O
be O O
effective O O
on O O
kashtartava S-Ds O
dysmenorrhoea S-Ds O
from O O
above O O
study O O
it O O
can O O
be O O
concluded O O
that O O
due O O
to O O
basti O O
chikitsa O O
vitiated O O
vata O O
dosha O O
gets O O
mitigated O O
and O O
hence O O
all O O
the O O
symptoms O O
diminish O O
and O O
it O O
has O O
been O O
observed O O
that O O
til O O
taila B-Dg O
matra I-Dg O
basti E-Dg O
is O O
very O O
effective O O
in O O
subjects O O
of O O
kashtartava S-Ds O
primary O O
dysmenorrhoea S-Ds O

